Tyler Shultz, former Theranos employee and whistleblower, told Y Combinator his first full day showed the launch was hollow. He started the Tuesday after Elizabeth Holmes, Theranos founder, cut the ribbon at a Palo Alto Walgreens. The assay validation manager quit that morning after a fight with Holmes and Sunny Balwani, then Theranos president. Shultz said managers admitted no test was validated on Theranos hardware, and Walgreens samples drew venous blood for Siemens machines and outside labs.
He stayed anyway.
Shultz said silos made real science impossible because his antibody team couldn't talk to the test developers who used its reagents. That secrecy was justified as protection against spies and against Quest Diagnostics and Labcorp, he said. An intern colleague warned him, "You shouldn't come back here," Shultz said. Within weeks Balwani moved every researcher into validation, where staff covered 24 hours and Balwani checked the lab at 3 a.m., Shultz said. The lab was called Normandy, pitched as storming health care, and its first validated assay was HBA1C, a notoriously easy test, he said.
Holmes recruited Shultz when he was a Stanford junior, urged him to switch from mechanical engineering to biology, and struck him as hypnotic and like the next Steve Jobs at the time. Balwani struck almost everyone the opposite way, and Shultz described his personality as gravel and cited texts about nailing sources. George Shultz, former Secretary of State, board member and Tyler's grandfather, trusted Holmes and welcomed her to family holidays, which let other directors defer to him, Shultz said. Reporter John Carreyrou later documented that deference in Bad Blood, while prosecutors argued the deference enabled years of fraud.
Theranos gave almost no stock options, Shultz said, so retention rested on visas, mortgages and fear, not upside. Holmes is serving a 10-year, three-month federal prison sentence for defrauding investors, per Britannica. If every bench scientist knew the device could not run hundreds of tests from a drop, who was supposed to stop patient testing first?
